Characterization of pharmaceutically active compounds in Dongting Lake, China: Occurrence, chiral profiling and environmental risk

Science of the Total Environment

Volumn 557-558, Issue , 2016, Pages 268-275

  Ma, Ruixue ^a   Wang, Bin ^a   Lu, Shaoyong ^b   Zhang, Yizhe ^a   Yin, Lina ^a   Huang, Jun ^a   Deng, Shubo ^a   Wang, Yujue ^a   Yu, Gang ^a  

^a TSINGHUA UNIVERSITY   (China)

^b Chinese Academy   (China)

Author keywords

Emerging contaminants; Enantiomer composition; Freshwater lake; PPCPs; Risk assessment

Indexed keywords

AMIDES; AQUATIC ORGANISMS; CAFFEINE; DRUG PRODUCTS; ENANTIOMERS; LAKES; RISK ASSESSMENT; WATER;

ANTI-INFLAMMATORY DRUGS; CHIRAL PHARMACEUTICALS; EMERGING CONTAMINANT; ENANTIOMERIC COMPOSITION; ENANTIOMERIC FRACTIONS; FRESH WATER LAKES; PHARMACEUTICALLY ACTIVE COMPOUNDS; PPCPS;

LAKE POLLUTION;

ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; CARBAMAZEPINE; DICLOFENAC; DIETHYLTOLUAMIDE; FLUOXETINE; IBUPROFEN; MEFENAMIC ACID; METOPROLOL; NAPROXEN; PROPRANOLOL; SURFACE WATER; TRIMETHOPRIM; VENLAFAXINE; DRUG;

CONCENTRATION (COMPOSITION); DRUG; ENVIRONMENTAL RISK; LAKE POLLUTION; PPCP; RISK ASSESSMENT; WASTEWATER;

AQUATIC SPECIES; ARTICLE; CHINA; CHIRALITY; CONCENTRATION (PARAMETERS); DRUG DETERMINATION; DRUG IDENTIFICATION; ENANTIOMER; ENANTIOSELECTIVITY; ENVIRONMENTAL ENRICHMENT; ENVIRONMENTAL MONITORING; FRESHWATER ENVIRONMENT; LAKE ECOSYSTEM; LIMIT OF DETECTION; LIMIT OF QUANTITATION; POLLUTION MONITORING; POLLUTION TRANSPORT; PRIORITY JOURNAL; RACEMIC MIXTURE; RISK ASSESSMENT; STEREOCHEMISTRY; WASTE WATER; WATER CONTAMINATION; ANALYSIS; CHEMISTRY; LAKE; WATER POLLUTANT;

CHINA; DONGTING LAKE; HUNAN;

AQUATIC ORGANISMS; CHINA; ENVIRONMENTAL MONITORING; LAKES; PHARMACEUTICAL PREPARATIONS; RISK ASSESSMENT; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

EID: 84961842124     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2016.03.053     Document Type: Article

References (67)

1. Agranat I., Wainschtein S.R., Zusman E.Z. The predicated demise of racemic new molecular entities is an exaggeration. Nat. Rev. Drug Discov. 2012, 11:972-973.
2. Backhaus T., Altenburger R., Arrhenius Å., Blanck H., Faust M., Finizio A., et al. The BEAM-project: prediction and assessment of mixture toxicities in the aquatic environment. Cont. Shelf Res. 2003, 23:1757-1769.
3. Bagnall J., Evans S., Wort M., Lubben A., Kasprzyk-Hordern B. Using chiral liquid chromatography quadrupole time-of-flight mass spectrometry for the analysis of pharmaceuticals and illicit drugs in surface and wastewater at the enantiomeric level. J. Chromatogr. A. 2012, 1249:115-129.
4. Barclay V.K., Tyrefors N.L., Johansson I.M., Pettersson C.E. Trace analysis of fluoxetine and its metabolite norfluoxetine. Part II: enantioselective quantification and studies of matrix effects in raw and treated wastewater by solid phase extraction and liquid chromatography-tandem mass spectrometry. J. Chromatogr. A. 2012, 1227:105-114.
5. Bendz D., Paxeus N.A., Ginn T.R., Loge F.J. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden. J. Hazard. Mater. 2005, 122:195-204.
6. Buser H.-R., Poiger T., Müller M.D. Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater. Environ. Sci. Technol. 1999, 33:2529-2535.
7. Carlsson C., Johansson A.-K., Alvan G., Bergman K., Kühler T. Are pharmaceuticals potent environmental pollutants?: part I: environmental risk assessments of selected active pharmaceutical ingredients. Sci. Total Environ. 2006, 364:67-87.
8. Chèvre N., Maillard E., Loepfe C., Becker-van Slooten K. Determination of water quality standards for chemical mixtures: extension of a methodology developed for herbicides to a group of insecticides and a group of pharmaceuticals. Ecotoxicol. Environ. Saf. 2008, 71:740-748.
9. Cleuvers M. Initial risk assessment for three β-blockers found in the aquatic environment. Chemosphere 2005, 59(2):199-205.
10. Commission. E. Technical Guidance Document on Risk Assessment in Support of Commission Directive 93/67/EEC on Risk Assessment for New Notified Substances Commission Regulation (EC) No 1488/94 on Risk Assessment for Existing Substances Directive 98/8/EC of the European Parliament and of the Council Concerning the Placing of Biocidal Products on the Market. Ispra (IT): European Commission Joint Research Centre EUR. 2003;20418.
11. Dai G., Wang B., Huang J., Dong R., Deng S., Yu G. Occurrence and source apportionment of pharmaceuticals and personal care products in the Beiyun River of Beijing, China. Chemosphere 2015, 119:1033-1039.
12. Daneshvar A., Aboulfadl K., Viglino L., Broséus R., Sauvé S., Madoux-Humery A.-S., et al. Evaluating pharmaceuticals and caffeine as indicators of fecal contamination in drinking water sources of the Greater Montreal region. Chemosphere 2012, 88:131-139.
13. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ. Health Perspect. 1999, 107:907.
14. De Andrés F., Castañeda G., Ríos Á. Use of toxicity assays for enantiomeric discrimination of pharmaceutical substances. Chirality 2009, 21:751-759.
15. Ellis J.B. Pharmaceutical and personal care products (PPCPs) in urban receiving waters. Environ. Pollut. 2006, 144:184-189.
16. Evans S.E., Davies P., Lubben A., Kasprzyk-Hordern B. Determination of chiral pharmaceuticals and illicit drugs in wastewater and sludge using microwave assisted extraction, solid-phase extraction and chiral liquid chromatography coupled with tandem mass spectrometry. Anal. Chim. Acta 2015.
17. Fang J., Wang Z., Zhao S., Li Y., Tang Z., Yu D., et al. Biodiversity changes in the lakes of the Central Yangtze. Front. Ecol. Environ. 2006, 4:369-377.
18. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 2006, 76:122-159.
19. Fono L.J., Sedlak D.L. Use of the chiral pharmaceutical propranolol to identify sewage discharges into surface waters. Environ. Sci. Technol. 2005, 39:9244-9252.
20. Huggett D., Brooks B., Peterson B., Foran C., Schlenk D. Toxicity of select beta adrenergic receptor-blocking pharmaceuticals (B-blockers) on aquatic organisms. Arch. Environ. Contam. Toxicol. 2002, 43:229-235.
21. Kasprzyk-Hordern B. Pharmacologically active compounds in the environment and their chirality. Chem. Soc. Rev. 2010, 39:4466-4503.
22. Kasprzyk-Hordern B., Baker D.R. Enantiomeric profiling of chiral drugs in wastewater and receiving waters. Environ. Sci. Technol. 2012, 46:1681-1691.
23. Kasprzyk-Hordern B., Dinsdale R.M., Guwy A.J. The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. Water Res. 2008, 42:3498-3518.
24. Kasprzyk-Hordern B., Kondakal V.V., Baker D.R. Enantiomeric analysis of drugs of abuse in wastewater by chiral liquid chromatography coupled with tandem mass spectrometry. J. Chromatogr. A. 2010, 1217:4575-4586.
25. Khan S.J., Wang L., Hashim N.H., Mcdonald J.A. Distinct enantiomeric signals of ibuprofen and naproxen in treated wastewater and sewer overflow. Chirality 2014, 26:739-746.
26. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 2002, 36:1202-1211.
27. Li H., Helm P.A., Metcalfe C.D. Sampling in the Great Lakes for pharmaceuticals, personal care products, and endocrine-disrupting substances using the passive polar organic chemical integrative sampler. Environ. Toxicol. Chem. 2010, 29:751-762.
28. Li Z.-H., Velisek J., Zlabek V., Grabic R., Machova J., Kolarova J., et al. Hepatic antioxidant status and hematological parameters in rainbow trout, Oncorhynchus mykiss, after chronic exposure to carbamazepine. Chem. Biol. Interact. 2010, 183:98-104.
29. Liang J., Liu J., Yuan X., Zeng G., Lai X., Li X., et al. Spatial and temporal variation of heavy metal risk and source in sediments of Dongting Lake wetland, mid-south China. J. Environ. Sci. Health A 2015, 50:100-108.
30. Liu J.-L., Wong M.-H. Pharmaceuticals and personal care products (PPCPs): a review on environmental contamination in China. Environ. Int. 2013, 59:208-224.
31. López-Serna R., Kasprzyk-Hordern B., Petrović M., Barcelóe D. Multi-residue enantiomeric analysis of pharmaceuticals and their active metabolites in the Guadalquivir River basin (South Spain) by chiral liquid chromatography coupled with tandem mass spectrometry. Anal. Bioanal. Chem. 2013, 405(18):5859-5873.
32. Madureira T.V., Barreiro J.C., Rocha M.J., Rocha E., Cass Q.B., Tiritan M.E. Spatiotemporal distribution of pharmaceuticals in the Douro River estuary (Portugal). Sci. Total Environ. 2010, 408:5513-5520.
33. Miege C., Choubert J., Ribeiro L., Eusèbe M., Coquery M. Fate of pharmaceuticals and personal care products in wastewater treatment plants-conception of a database and first results. Environ. Pollut. 2009, 157:1721-1726.
34. Morelli F., Kubicka A.M., Tryjanowski P., Nelson E. The vulture in the Sky and the hominin on the land: three million years of human-vulture interaction. Anthrozoos. 2015, 28:449-468.
35. Murray K.E., Thomas S.M., Bodour A.A. Prioritizing research for trace pollutants and emerging contaminants in the freshwater environment. Environ. Pollut. 2010, 158:3462-3471.
36. Oaks J.L., Gilbert M., Virani M.Z., Watson R.T., Meteyer C.U., Rideout B.A., et al. Diclofenac residues as the cause of vulture population decline in Pakistan. Nature 2004, 427:630-633.
37. Qi W., Müller B., Pernet-Coudrier B., Singer H., Liu H., Qu J., et al. Organic micropollutants in the Yangtze River: seasonal occurrence and annual loads. Sci. Total Environ. 2014, 472:789-799.
38. Ribeiro A.R., Castro P.M., Tiritan M.E. Environmental fate of chiral pharmaceuticals: determination, degradation and toxicity. Environmental Chemistry for a Sustainable World 2012, 3-45. Springer.
39. Ribeiro A.R., Castro P.M., Tiritan M.E. Chiral pharmaceuticals in the environment. Environ. Chem. Lett. 2012, 10:239-253.
40. Ribeiro A.R., Maia A.S., Cass Q.B., Tiritan M.E. Enantioseparation of chiral pharmaceuticals in biomedical and environmental analyses by liquid chromatography: an overview. J. Chromatogr. B 2014, 968:8-21.
41. Ribeiro A.R., Santos L.H., Maia A.S., Delerue-Matos C., Castro P.M., Tiritan M.E. Enantiomeric fraction evaluation of pharmaceuticals in environmental matrices by liquid chromatography-tandem mass spectrometry. J. Chromatogr. A. 2014, 1363:226-235.
42. Richardson S.D., Ternes T.A. Water analysis: emerging contaminants and current issues. Anal. Chem. 2005, 77:3807-3838.
43. Schwaiger J., Ferling H., Mallow U., Wintermayr H., Negele R. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac: part I: histopathological alterations and bioaccumulation in rainbow trout. Aquat. Toxicol. 2004, 68:141-150.
44. Shultz S., Baral H.S., Charman S., Cunningham A.A., Das D., Ghalsasi G., et al. Diclofenac poisoning is widespread in declining vulture populations across the Indian subcontinent. Proc. R. Soc. Lond. B Biol. Sci. 2004, 271:S458-S460.
45. Silva E., Rajapakse N., Kortenkamp A. Something from "nothing"-eight weak estrogenic chemicals combined at concentrations below NOECs produce significant mixture effects. Environ. Sci. Technol. 2002, 36:1751-1756.
46. Stanley J.K., Ramirez A.J., Chambliss C.K., Brooks B.W. Enantiospecific sublethal effects of the antidepressant fluoxetine to a model aquatic vertebrate and invertebrate. Chemosphere 2007, 69:9-16.
47. Sui Q., Huang J., Deng S., Yu G., Fan Q. Occurrence and removal of pharmaceuticals, caffeine and DEET in wastewater treatment plants of Beijing, China. Water Res. 2010, 44:417-426.
48. Tang J., Shi T., Wu X., Cao H., Li X., Hua R., et al. The occurrence and distribution of antibiotics in Lake Chaohu, China: seasonal variation, potential source and risk assessment. Chemosphere 2015, 122:154-161.
49. Ternes T.A. Analytical methods for the determination of pharmaceuticals in aqueous environmental samples. TrAC Trends Anal. Chem. 2001, 20:419-434.
50. TGD E. Technical Guidance Document on Risk Assessment in Support of Commission Directive 93/67/EEC on Risk Assessment for New Notified Substances, Commission Regulation (EC) No 1488/94 on Risk Assessment for Existing Substances, and Directive 98/8/EC of the European Parliament and of the Council Concerning the Placing of Biocidal Products on the Market. Part I-IV, European Chemicals Bureau (ECB), JRC-Ispra (VA), Italy, April 2003. Part II European Commission Joint Research Centre EUR. 2003;20418.
51. Valcárcel Y., Alonso S.G., Rodríguez-Gil J., Gil A., Catalá M. Detection of pharmaceutically active compounds in the rivers and tap water of the Madrid Region (Spain) and potential ecotoxicological risk. Chemosphere 2011, 84:1336-1348.
52. Vergeynst L., Haeck A., De Wispelaere P., Langenhove H., Demeestere K. Multi-residue analysis of pharmaceuticals in wastewater by liquid chromatography-magnetic sector mass spectrometry: Method quality assessment and application in a Belgian case study. Chemosphere 2015, 119:S2-S8.
53. Vieno N.M., Härkki H., Tuhkanen T., Kronberg L. Occurrence of pharmaceuticals in river water and their elimination in a pilot-scale drinking water treatment plant. Environ. Sci. Technol. 2007, 41:5077-5084.
54. Wang L., Ying G.-G., Zhao J.-L., Yang X.-B., Chen F., Tao R., et al. Occurrence and risk assessment of acidic pharmaceuticals in the Yellow River, Hai River and Liao River of north China. Sci. Total Environ. 2010, 408:3139-3147.
55. Wu C., Huang X., Witter J.D., Spongberg A.L., Wang K., Wang D., et al. Occurrence of pharmaceuticals and personal care products and associated environmental risks in the central and lower Yangtze River, China. Ecotox. Environ. Saf. 2014, 106:19-26.
56. Wu M., Xiang J., Que C., Chen F., Xu G. Occurrence and fate of psychiatric pharmaceuticals in the urban water system of Shanghai, China. Chemosphere 2015, 138:486-493.
57. Xu W., Yan W., Li X., Zou Y., Chen X., Huang W., et al. Antibiotics in riverine runoff of the Pearl River Delta and Pearl River Estuary, China: concentrations, mass loading and ecological risks. Environ. Pollut. 2013, 182:402-407.
58. Yamamoto H., Nakamura Y., Moriguchi S., Nakamura Y., Honda Y., Tamura I., et al. Persistence and partitioning of eight selected pharmaceuticals in the aquatic environment: laboratory photolysis, biodegradation, and sorption experiments. Water Res. 2009, 43:351-362.
59. Yan C., Yang Y., Zhou J., Liu M., Nie M., Shi H., et al. Antibiotics in the surface water of the Yangtze estuary: occurrence, distribution and risk assessment. Environ. Pollut. 2013, 175:22-29.
60. Yan Z., Yang X., Lu G., Liu J., Xie Z., Wu D. Potential environmental implications of emerging organic contaminants in Taihu Lake, China: comparison of two ecotoxicological assessment approaches. Sci. Total Environ. 2014, 470:171-179.
61. Yang Y., Fu J., Peng H., Hou L., Liu M., Zhou J. Occurrence and phase distribution of selected pharmaceuticals in the Yangtze estuary and its coastal zone. J. Hazard. Mater. 2011, 190:588-596.
62. Yu Y., Huang Q., Wang Z., Zhang K., Tang C., Cui J., et al. Occurrence and behavior of pharmaceuticals, steroid hormones, and endocrine-disrupting personal care products in wastewater and the recipient river water of the Pearl River Delta, South China. J. Environ. Monitor. 2011, 13:871-878.
63. Zhang L., Yu W., Rong Y., Guo X., Ye J., Shen Z., et al. Enantiomeric separation of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs and β-blockers by RP-HPLC using an amylose chiral stationary phase for the enantioselective skin permeation study. Anal. Methods 2014, 6:6058-6065.
64. Zhao J.L., Ying G.G., Liu Y.S., Chen F., Yang J.F., Wang L., et al. Occurrence and a screening-level risk assessment of human pharmaceuticals in the Pearl River system, South China. Environ. Toxicol. Chem. 2010, 29:1377-1384.
65. Zhou L.-J., Ying G.-G., Zhao J.-L., Yang J.-F., Wang L., Yang B., et al. Trends in the occurrence of human and veterinary antibiotics in the sediments of the Yellow River, Hai River and Liao River in northern China. Environ. Pollut. 2011, 159:1877-1885.
66. Zhu S., Chen H., Li J. Sources, distribution and potential risks of pharmaceuticals and personal care products in Qingshan Lake basin, Eastern China. Ecotox. Environ. Saf. 2013, 96:154-159.
67. Zou S., Xu W., Zhang R., Tang J., Chen Y., Zhang G. Occurrence and distribution of antibiotics in coastal water of the Bohai Bay, China: impacts of river discharge and aquaculture activities. Environ. Pollut. 2011, 159:2913-2920.